3 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 3 of 3 clinical reviews.
Board-reviewed clinical guide on managing the Addyi (flibanserin) efficacy plateau, including FDA-approved dosing, titration strategy, dropout predictors, and when to stop treatment.
A clinician-reviewed guide to flibanserin (Addyi) dosing, titration rationale, the 100 mg bedtime ceiling, real-world adherence data, and evidence-based next steps when standard dosing falls short.
Evidence-based guide to restarting flibanserin (Addyi) after a break. Covers re-titration protocol, expected timelines, alcohol rules, and when to expect results based on BEGONIA trial data.